Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Analgesic Efficacy of Continuous Sub-fascial Bupivacaine Infusion and Lidocaine Patches in Post-cesarean Patients With Opiate Use Disorder: A Comparative Efficacy Analysis

NCT04033562 is registered in ClinicalTrials.gov with WellSpan Health as lead sponsor.

NCT NCT04033562
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04033562 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Analgesic Efficacy of Continuous Sub-fascial Bupivacaine Infusion and Lidocaine Patches in Post-cesarean Patients With Opiate Use Disorder: A Comparative Efficacy Analysis
Lead sponsor
WellSpan Health
Phase
Phase 4
Overall status
Terminated
Start date
January 15, 2020
Completion date
May 17, 2021
Enrollment
2 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ambu action, cesarean section, infusion catheter, wound, lidopatch, medication assisted treatment, opioid abuse, opioid dependence, opioid use, opioid-use disorder, pregnancy related